The expression of cyclooxygenase-2 (COX-2) and cell-cycle proteins (p21 and p27) proves useful in predicting prognosis and orientating therapy in many malignant tumours. Malignant pleural mesothelioma is an uncommon and lethal cancer for which there are limited treatment options. In this study, we evaluated the impact on prognosis and the influence on therapeutic strategy of immunohistochemical expression of COX-2, p21 and p27 in specimens from patients treated for malignant pleural mesothelioma.
Mineo, T.c., Ambrogi, V., Cufari, M., Pompeo, E. (2010). May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 38(3), 245-252 [10.1016/j.ejcts.2010.02.012].
May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
MINEO, TOMMASO CLAUDIO;AMBROGI, VINCENZO;POMPEO, EUGENIO
2010-09-01
Abstract
The expression of cyclooxygenase-2 (COX-2) and cell-cycle proteins (p21 and p27) proves useful in predicting prognosis and orientating therapy in many malignant tumours. Malignant pleural mesothelioma is an uncommon and lethal cancer for which there are limited treatment options. In this study, we evaluated the impact on prognosis and the influence on therapeutic strategy of immunohistochemical expression of COX-2, p21 and p27 in specimens from patients treated for malignant pleural mesothelioma.| File | Dimensione | Formato | |
|---|---|---|---|
|
COXMESOTHELEJCTS(ULTIMO)2010.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
313.53 kB
Formato
Adobe PDF
|
313.53 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
